<DOC>
	<DOCNO>NCT01556386</DOCNO>
	<brief_summary>This study find distribution genetic polymorphism gene relate chemotherapeutic drug ALL .</brief_summary>
	<brief_title>Pharmacogenetic Analysis Korean Pediatric Patients With Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description>Cure rate pediatric ALL dramatically improve 80 % . Resistance drug hematologic relapse remain problem ALL treatment . One explanation drug resistance toxicity pharmacogenetic effect . Germline polymorphisms gene code protein involve pharmacokinetics pharmacodynamics antileukemic agent various , inter-patient variability main factor pharmacogenetic difference . Since multiple chemotherapeutic agent involve treat ALL , many gene relate metabolic pathway drug effect pharmacokinetics patient ALL . In Korea , pharmacogenetic study include multiple genetic locus pediatric ALL reported.In study , distribution genetic polymorphism gene relate antileukemic drug analyze , relation outcome treatment relapse rate assess .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>Clinical diagnosis acute lymphoblastic leukemia In case inform consent assent Paients parent refusal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>acute lymphoblastic leukemia</keyword>
	<keyword>single nucleotide polymorphism</keyword>
</DOC>